| Please register to receive the benefits of our network-wide features. |
Register (free) |
Log In
|
| Please register to receive the benefits of our network-wide features. |
Register (free) |
Log In
|
David Ewing Duncan and Dr. Moira Gunn speak with Joshua Boger, the President and CEO of Vertex Pharmaceuticals. They discuss rational drug design: how Vertex re-engineered their HIV/AIDS drug into one for Hepatitis C.
This program is from our Tech Nation series.
For The Conversations Network:
Play